Moxalactam disodium-induced pulmonary hemorrhage.
Fatal pulmonary hemorrhage occurred on the eighth day of moxalactam therapy. No other pharmacologic agent or obvious cause could be attributed to the hemoptysis. Moxalactam-induced pulmonary hemorrhage should be included in the differential diagnosis of an infiltrate when moxalactam is being administered.
D000368:Aged; D006469:Hemoptysis / Q000139:chemically induced; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D007416:Intestinal Perforation / Q000601:surgery; D007421:Intestine, Small / Q000293:injuries; D008171:Lung Diseases / Q000139:chemically induced*; D008297:Male; D009070:Moxalactam / Q000009:adverse effects*; D011182:Postoperative Care
D009070:Moxalactam